AcquisitionOther
Garda Therapeutics acquired Assertio Holdings, Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Garda Therapeutics -> Assertio Holdings, Inc. · $125.1 million
Acquisition of Rolvedon asset through definitive agreement and strategic pharmaceutical portfolio expansion.
Open source record (SEC) ↗